Group Mailing 2000-08-15

Priority Lists

Disease Committee	Last Changed
Breast Cancer	11/1/23
Cancer Care Delivery	9/1/22
Cancer Survivorship	1/14/19
comboMATCH	12/1/23
Early Therapeutics & Rare Cancers	12/1/23
Gastrointestinal Cancer	12/1/23
Genitourinary Cancer	12/1/23
Head and Neck Cancer	12/15/07
iMATCH	11/1/22
Immunomolecular Therapeutics	6/15/20
Leukemia	3/22/23
Lung Cancer	12/1/23
LungMAP	12/15/23
Lymphoma	1/17/24
Melanoma	4/18/22
Myeloma	4/1/24
Other	2/1/14
Prevention & Epidemiology	7/1/24
Symptom Control and Quality of Life	4/1/23

S9716Phase II

A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)

Study Coordinator(s)	Raymond A. Kempf, M.D., MPH, Ralph J. Tuthill, M.D.
Participants	Members, NCORP
Closure Date	2000-08-15

S9810Phase II

A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma

Study Coordinator(s)	Robert N. Taub, M.D.,Ph.D., Mary Louise Keohan, M.D.
Participants	Members, Medical Oncologists, NCORP
Closure Date	2000-08-15

A Phase II Trial of Complete Surgical Resection for Stage IV Melanoma-Surgical Resection with Biological and Clinical Follow-Up

Study Coordinator(s)	Jeffrey A. Sosman, M.D., Vernon K. Sondak, M.D., James A. Warneke, M.D., Cecilia M. Fenoglio-Preiser, M.D., Ralph J. Tuthill, M.D.
Participants	Members, NCORP, Medical Oncologists, Pathologists, Surgeons, ECOG